|
71 |
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
Enthalten in Neurological research and practice Bd. 4, 23.5.2022, Nr. 1, date:12.2022: 1-7
|
|
|
|
72 |
Anästhesie zur Thrombektomie
Enthalten in Der Anaesthesist Bd. 66, 5.7.2017, Nr. 9, date:9.2017: 714-716
|
|
|
|
73 |
Anaplastische Gliome
Enthalten in Der Nervenarzt Bd. 81, 17.7.2010, Nr. 8, date:8.2010: 928-935
|
|
|
|
74 |
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
Enthalten in Acta neuropathologica Bd. 129, 27.11.2014, Nr. 1, date:1.2015: 133-146
|
|
|
|
75 |
Automated volumetric assessment with artificial neural networks might enable a more accurate assessment of disease burden in patients with multiple sclerosis
Enthalten in European radiology Bd. 30, 3.1.2020, Nr. 4, date:4.2020: 2356-2364
|
|
|
|
76 |
Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma
Enthalten in Journal of cancer research and clinical oncology Bd. 146, 21.11.2019, Nr. 3, date:3.2020: 659-670
|
|
|
|
77 |
Brain Tumor Networks in Diffuse Glioma
Enthalten in Neurotherapeutics Bd. 19, 10.11.2022, Nr. 6, date:10.2022: 1832-1843
|
|
|
|
78 |
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
Enthalten in Acta neuropathologica Bd. 140, 8.7.2020, Nr. 3, date:9.2020: 409-413
|
|
|
|
79 |
Chemotherapy for intracranial ependymoma in adults
Enthalten in BMC cancer Bd. 16, 23.4.2016, Nr. 1, date:12.2016: 1-12
|
|
|
|
80 |
Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p
Enthalten in Acta neuropathologica Bd. 136, 31.10.2018, Nr. 6, date:12.2018: 975-978
|
|
Administration
